Open AccessAcute bacterial endophthalmitis following dexamethasone intravitreal implant: A case report
Author(s) -
Waseem Al Zamil,
Sanaa A. Yassin
Publication year - 2019
Publication title -
saudi journal of medicine and medical sciences
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 2
eISSN - 1658-631X
pISSN - 2321-4856
DOI - 10.4103/sjmms.sjmms_57_17
Subject(s) - medicine , endophthalmitis , dexamethasone , implant , blurred vision , ceftazidime , ophthalmology , retinal vein , macular edema , surgery , occlusion , retinal , pseudomonas aeruginosa , genetics , biology , bacteria
A 54-year-old male presented to our ophthalmology clinic with a diagnosis of the right central retinal vein occlusion with macular edema. The patient was treated with dexamethasone intravitreal implant. Three days after the implant insertion, the patient experienced pain, redness and blurred vision in the same eye. With a provisional diagnosis of acute endophthalmitis, a combination of ceftazidime 2.25 mg/0.1 ml and vancomycin 1 mg/0.1 ml was injected intravitreally. One week after the treatment, endophthalmitis signs and symptoms subsided. This report presents a case of endophthalmitis following dexamethasone intravitreal implant, with a favorable outcome after treatment with intravitreal antibiotic injection without removal of the implant.